Although the role of miR-205 has been widely elucidated, the function of its host gene (MIR205HG) is yet to be clarified. We have recently investigated whether this gene is a simple endorsement for miRNA production or it may act independently, demonstrating its action as nuclear long noncoding RNA able to control basalluminal differentiation in the human prostate context, thus deserving the reannotation as LEADR, Long Epithelial Alu-interacting Differentiation-related RNA. Here, we describe the loss and gain of function approaches experimentally used to modulate LEADR expression, and the bioinformatic procedures employed to analyze microarray data in our published article "LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation" [1] . The high reproducibility of replicates, the strong concordance with a validation technique, and the coherent behavior observed for differentially expression features, both in terms of single genes and deregulated pathways, not only support the quality of the data, but also endorse their potential reuse. Very relevant are the diverse silencing and overexpression strategies employed (all of which analyzed in multiple biologically independent replicates), which should allow other scientists to analyze our dataset for the specific purpose of their research, may it be the study of MIR205HG function as miRNA host gene, the investigation of its miRNAindependent biological role or again the dissection of Alu
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Although the role of miR-205 has been widely elucidated, the function of its host gene (MIR205HG) is yet to be clarified. We have recently investigated whether this gene is a simple endorsement for miRNA production or it may act independently, demonstrating its action as nuclear long noncoding RNA able to control basalluminal differentiation in the human prostate context, thus deserving the reannotation as LEADR, Long Epithelial Alu-interacting Differentiation-related RNA. Here, we describe the loss and gain of function approaches experimentally used to modulate LEADR expression, and the bioinformatic procedures employed to analyze microarray data in our published article "LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation" [1] . The high reproducibility of replicates, the strong concordance with a validation technique, and the coherent behavior observed for differentially expression features, both in terms of single genes and deregulated pathways, not only support the quality of the data, but also endorse their potential reuse. Very relevant are the diverse silencing and overexpression strategies employed (all of which analyzed in multiple biologically independent replicates), which should allow other scientists to analyze our dataset for the specific purpose of their research, may it be the study of MIR205HG function as miRNA host gene, the investigation of its miRNAindependent biological role or again the dissection of Alu sequence involvement in the mechanism of action of long noncoding RNAs, which is a hot topic in the field. Value of the Data To our knowledge this dataset is the first-in-class transcriptomic profile obtained on human prostate cells modulated for MIR205HG and therefore it is a unique resource. Our dataset may be useful to all researchers interested in investigating MIR205HG function, which is still a largely unexplored field.
The different silencing and overexpression strategies used could stimulate other scientists to consider our dataset for their specific research purpose concerning the study of MIR205HG itself, of the hosted miR-205 and their interaction or of the Alu contribution in the MIR205HG function.
Data description

Experimental plan
The precursor sequence of human miR-205 is located on the positive strand of the chr1q32 region and spans the last intron/exon junction of a gene originally named as NPCA-5 (alias LOC642587). Given that no protein product has been experimentally observed, this gene was re-named as miR-205 Host Gene (MIR205HG) in the assumption that it merely hosts miR-205. Nonetheless, latest researches have started to shed light on a possible regulatory role of MIR205HG as competing endogenous RNA, sponging miR-590 and miR-122 in head and neck and cervical tumors respectively [2, 3] .
In this regard, we have investigated, for the first time, the function of MIR205HG in human prostate, thus discovering that it is mostly expressed in the basal layer of epithelium, and progressively lost during luminal differentiation and tumorigenesis [1] . MIR205HG processed transcripts behave as nuclear intergenic long noncoding RNAs (lincRNAs), able per se to regulate basal-luminal differentiation, through the repression of the interferon pathway [1] . Mechanistically, we hypothesized that, by means of an Alu-like element present in the second exon, MIR205HG directly binds to the promoter regions of target genes, which are characterized themselves by an Alu element in proximity of an interferonregulatory factor (IRF) binding site. In addition, we experimentally observed that this lincRNA interacts with IRF1 protein, thus modulating its occupancy on target genes. In line with this evidence, we proposed MIR205HG as a buffer of IRF1 transcription factor activity [1] .
Since MIR205HG operates autonomously from miR-205 and all its isoforms could be considered functionally active due to the presence of the Alu element, we decided to re-annotate it as LEADR [1] .
In Profumo, Forte, Percio, Rotundo et al. [1] , our main goal was to discover LEADR biological role in human prostate cells, and here we describe, in detail, the employed experimental procedures. Basically, we adopted gain and loss of function approaches to modify LEADR levels in different prostate cell lines and analyzed the consequent gene expression changes. Aside the techniques used to modulate LEADRspecific transcripts only, we also considered both the modification of its entire locus (including miR-205) and the overexpression of transcripts deleted for functional elements (i.e. Alu) (Fig. 1) .
Transcriptome changes were measured through hybridization on a microarray platform comparing the different perturbations of LEADR expression operated in normal and tumor prostate cell lines (RWPE-1 and DU145, respectively).
Gene expression profile analysis led us to unearth LEADR function in prostate cells and speculate about the mechanism through which it regulates the transcription of its target genes. Asides this, our experiments could have a value for potential reuse in taking researchers to the discovery of new biological functions of LEADR. Therefore, the dataset described here paves the way for a better characterization of LEADR gene and a clarification of its transcriptional/functional interplay with the hosted miR-205.
Preprocessing pipeline and biological replicate management
Transcriptomic quantification from prostate cells modulated for LEADR expression was generated in our laboratory as three independent microarray experiments. For each dataset, the same preprocessing pipeline was applied (Fig. 2a) , consisting of robust spline normalization (rsn) and filtering of low quality data. As illustrated in the box plots (Fig. 2b) , this method confers a more stable inference even if the number of arrays is small, and it is able to remove any fluctuation due to systematic bias. Around 25% of probes in each microarray experiment showed sufficient quality to pass the threshold (Fig. 2a) .
Several biological replicates for each modulation were introduced in the experimental design to enhance the statistical power and improve robustness of the biological variability estimation in the subsequent bioinformatic analyses. Specifically, all experiments were conducted as independent biological triplicates, except for the overexpression of LEADR RefSeq transcript and gene, which were performed as quadruplicates.
Principal component analysis (PCA) was performed to evaluate the quality of biological replicates in terms of explained variance. Upon plotting all samples in the space of principal components, a clear segregation between replicates and other samples emerged in each dataset (Fig. 2c) . The sample distribution showed a good congruency among the biological replicates confirming data consistency and reproducibility.
Evaluation of transfection efficacy
Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) was used to validate LEADR silencing in RWPE-1 cells upon transfection with siRNA or gapmers (Fig. 3a) . Raw data (total number of probes is indicated in brackets) obtained by the hybridization on Illumina HumanHT-12 v4 chips were log 2 -transformed and normalized according to the rsn method. Probes with both at least one significant detection p-value (threshold of 0.01) and an associated official gene symbol were considered. Among filtered probes, for those with the same gene symbol, the probe with the highest variance was selected. For each of the three datasets, the final normalized matrix of expression profile was obtained (the number of retained probes is indicated in brackets) and used for differential expression analysis (a). Box plots for each GEO dataset with raw expression (top) and rsn normalized values (bottom), respectively (b). Scatter plot of sample distribution in the space of principal components (PCs) for each GEO dataset. Replicates affected by the same modulation are indicated with the same color (c).
Graphs confirmed a general abrogation of LEADR expression. All oligomers showed similar performance in terms of silencing efficacy across biological replicates, though the reduction of LEADR was overall more pronounced with gapmers as compared to siRNA. Specifically, the gapmer designed to target an intron within LEADR primary transcript (gapINT1) revealed to be able to reduce both LEADR and miR-205 expression levels (Fig. 3a) .
In addition, the efficacy of transfection with siRNA and gapmers in RWPE-1 cells was supported by changes in morphology, as assessed through bright-field imaging in Profumo, Forte, Percio, Rotundo et al. [1] .
Morphological changes were appreciable also in DU145 cells transfected with either the entire LEADR gene or the RefSeq transcript, as compared to cells transfected with the empty vector (EV) (Fig. 3b) . Consistent with this change, LEADR resulted to be overexpressed in both cases (Fig. 3c) . Notably, transfection of the entire locus was reflected by a higher level of both LEADR and miR-205, while that of the RefSeq sequence showed an increase of LEADR only (Fig. 3c ). Changes were consistent across biological replicates. In overexpression experiments conducted with the RefSeq transcript deleted for the portion of the Alu element, LEADR expression levels increased more than ten times with respect to the control. This result corroborates the efficacy of the transfection albeit LEADR transcript was deprived of the Alu element, which is extremely important for its function as described in Profumo, Forte, Percio, Rotundo et al. [1] . Moreover, end point RT-PCR of RNA extracted from DU145 cells transfected with either LEADR RefSeq or correspondent Alu-deleted transcript showed amplicons of different molecular weight, confirming transcription of a shorter LEADR sequence in DAlu-cells (Fig. 3d ).
Bioinformatic analyses
Transcriptomic changes arising from LEADR modulation were analyzed to infer LEADR function in prostate cells. We expected to observe an opposite trend according to the alterations induced in the two different cell lines (silencing vs. overexpression). Prevalently, LEADR revealed to have a repressive attitude since most of the genes were up-regulated upon its silencing (Fig. 4a) . In line with this evidence, the up-regulated genes showed more overlap in all the three silencing experiments than the down-regulated ones, as reported in the Venn diagrams (Fig. 4a) .
As a complementary approach, we ectopically expressed the RefSeq or gene sequences in DU145 cells and observed a high overlap in terms of both up-and down-regulated genes (Fig. 4b) . Moreover, we wondered whether the genes overlapping across silencing experiments showed an opposite trend upon LEADR overexpression. This resulted to be the case, as major overlap was observed between genes up-regulated upon silencing and those down-regulated upon overexpression, as clearly illustrated in Profumo, Forte, Percio, Rotundo et al. [1] . Such evidence prompted us to focus on these genes as bona fide LEADR direct targets [1] .
In order to corroborate our hypothesis, we applied a holist approach evaluating the concordance in terms of pathway modulation on genes commonly up-regulated upon silencing (65 genes according to the Venn diagram in Fig. 4a, right) and genes commonly down-regulated upon overexpression (97 genes according to the Venn diagram in Fig. 4b, left) . On these selections, we performed an overrepresentation analysis investigating a possible enrichment of general molecular mechanisms belonging to the Hallmark collection of the MSigDB database [4] . Interestingly, we observed a high overlap among gene sets: the two lists of hallmarks shared seven pathways, though different for rank and size, with interferon pathways at the top of both rankings (Fig. 4c) .
Overall, bioinformatic analyses revealed a strong concordance among LEADR modulations and a good coherence (albeit the sign of expression) between LEADR silencing and overexpression, thus highlighting the efficacy and the correctness of the experimental procedure.
Technical validation of microarray measurement
To confirm the validity of high-throughput microarray measures, we randomly selected 28 genes commonly modulated across LEADR silencing experiments in RWPE-1 cells, and we evaluated their expression levels using an independent technique, namely TaqMan-based qRT-PCR, in RWPE-1 cells transfected with gapLEADR and gapCTR. Plotting fold change (FC) values of both qRT-PCR and microarray analyses, a strong linear relationship clearly emerged (Fig. 4d) , suggesting a considerable concordance in terms of trend and magnitude. Overall, this observation corroborates the quality and the informativeness of our high-throughput data, thus stimulating their potential reuse by other authors for the discovery of new LEADR functions.
Data records
Raw and normalized gene expression data in the study have been deposited at Gene Expression Omnibus as a superseries with the accession number GSE104003. This superseries is composed of three different datasets (GEO103654, GEO103655, and GEO103656), each one including LEADR modulation experiments and relative controls, as previously described (Table 1) . 
LEADR modulation
We silenced LEADR in RWPE-1 cell line, a human normal prostate model, where it is endogenously expressed at high levels. To solely abrogate LEADR expression, a single-stranded LNA/DNA/LNA antisense gapmer (gapLEADR) or a conventional small interfering RNA (siLEADR), both complementary to an exon/exon junction in RefSeq sequence, were employed (Fig. 1) . Gapmer nuclear translocation and RNAse H-mediated cleavage prompted us to adopt this approach to improve the efficacy of silencing in this compartment, which we and others demonstrated to be the main LEADR subcellular localization [1, 2] . Another gapmer (gapINT1) was designed to target an intron within LEADR primary transcript (Fig. 1) , and we showed that it was able to reduce the expression of both LEADR and miR-205 [1] . This strategy was employed to study a possible transcriptional and functional relationship between LEADR and its hosted miRNA. In addition, a control siRNA (siCTR) and gapmer (gapCTR) with no homology to any known human mRNA were used for comparative analyses.
We reconstituted LEADR expression by stably transfecting plasmid vectors containing either the full length (hereafter gene) or the RefSeq transcript sequences in DU145 cell line (Fig. 1) , a human prostate cancer model, where both LEADR and miR-205 are normally not expressed.
In addition, in the same cell line, a vector containing the RefSeq sequence deleted for a portion of the Alu element (DAlu) was introduced to study the impact of this depletion on LEADR regulatory functions (Fig. 1 ). An empty vector was included in all experiments as control (EV).
RNA isolation and microarray hybridization
Total RNA was isolated from stable clones of DU145 overexpressing LEADR transcripts (gene, RefSeq or DAlu) or from RWPE-1 cells transiently silenced for LEADR expression (gapLEADR, siLEADR or gapINT1) 72 hours upon transfection. RNA was extracted with Qiazol reagent and purified with QIAGEN RNeasy mini kit (QIAGEN, Hilden, Germany) in accordance with the prescribed protocol. DNase I treatment was performed, and the quality of extracted RNA was evaluated through Agilent Bioanalyzer. Eight hundred ng of total RNA was reverse transcribed, labelled with biotin, and amplified overnight using the Illumina RNA TotalPrep Amplification kit (Thermo Fisher) according to manufacturer's protocol. One mg of the biotinylated cRNA was mixed with the Hyb E1 hybridization buffer and hybridized to the Illumina HumanHT-12 v4 chips (47,323 probes) at 58 C overnight. Array chips were washed with manufacturer's E1BC solution, stained with 1 mg/mL Cy3-streptavidine, and scanned with the Illumina BeadArray Reader according to the standard Illumina protocols.
Preprocessing methods
Raw data were log 2 -transformed and normalized by using the rsn method implemented in the lumi package to deal with intensity-dependent and spatial bias [5] . Furthermore, normalized data were filtered by retaining probes with both at least one detection p-value < 0.01 across samples and an associated official gene symbol. For probes mapping on the same gene symbol, the one with the highest variance was selected.
Differential expression analyses
Differential expression was measured in terms of fold change (FC) using the limma package of R environment [6] . In general, significance was assessed in terms of False Discovery Rate (FDR) to manage multiple test comparisons (threshold of 0.05). However, only few genes resulted significantly differentially expressed in terms of FDR correction in overexpression experiments. In this regard, such experiments have an intrinsic higher variability due to biological and technical causes. For example, since the DU145 cell line model does not constitutively express basal features, the sole reconstitution of LEADR could not be sufficient to induce the acquisition of a frankly basal phenotype, thus resulting in a hybrid state with marginal gene expression changes. Moreover, transfected cells have had the possibility to settle into plasmid integration for a long time, and they might have therefore adapted to this condition (in our case, we collected transcriptomic profile of stable clones of DU145 cells, while for silencing experiments performed in RWPE-1 cells we evaluated gene expression acutely 3 days after transfection). In this regard, we reasoned that FDR is a too restrictive correction for overexpression experiments, and we considered as significantly differentially expressed all genes with at least a nominal p-value < 0.05. The overrepresentation analysis was conducted retaining only the significant enrichment scores (FDR threshold of 0.05).
Analysis of qRT-PCR data
In TaqMan-based 
